The global IVD antibodies market is projected to grow at a healthy CAGR of around 3.8% during the forecast period between 2022 and 2032, reaching a valuation of nearly USD 1.38 Billion by 2022. Demand for IVD antibodies is driven by the rising prevalence of chronic and infectious diseases worldwide and the increasing need for early diagnosis of chronic diseases to initiate proper treatment.
| Report Attribute | Details |
|---|---|
| IVD Antibodies Market Estimated Growth Rate (2022 to 2032) | 3.8% CAGR |
| IVD Antibodies Market Projected Size (2022) | USD 1.38 Billion |
| IVD Antibodies Market Projected Size (2032) | USD 2 Billion |
As the global burden of chronic and infectious diseases continues to escalate, medical professionals and researchers are looking for innovative techniques and technologies to diagnose diseases at their early stages. This has put the in-vitro diagnostic (IVD) antibodies market into the spotlight.
IVD antibodies are unique diagnostic tools used for clinical diagnostics and research applications. They have become a critical component of many diagnostic assays used to detect and diagnose numerous chronic and infectious diseases such as cancer, tuberculosis, HIV etc. These IVD antibodies help medical professionals to detect and diagnose diseases at early stages, thereby allowing them to initiate proper treatment approaches.
In recent years, demand for IVD antibodies has risen at a robust pace due to increasing popularity of immunology methods such as sandwich ELISA and immunonephelometry and this trend is likely to continue during the forecast period.
Consequently, increasing proteomics and genomics research activities along with rising consumer inclinations towards opting for novel diagnostic techniques will create space for IVD antibodies market growth in the future.
By applications, FMI predicts that the cancer segment will continue to dominate the global IVD antibodies market due to the increasing incidence of cancer and a rise in cancer diagnostic screening.
Increasing incidence of chronic and infectious diseases such as HIV, hepatitis, cancer, cardiovascular diseases, malaria, hepatitis, etc., across the world is a major factor driving the growth in IVD antibodies market and the trend is likely to continue during the forecast period.
IVD antibodies have become highly sought-after diagnostic products used across diagnostic laboratories and hospitals for early and accurate detection of diseases like Cancer. Thus, rapid surge in cases of various types of cancer globally will eventually boost the growth of IVD antibodies market during the forecast period.
As per the American Cancer Society, the global cancer burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. This will create immense opportunities for IVD antibodies manufacturers during the forthcoming years.
Similarly, increasing research and development coupled with rising investments by government and non-government organizations in medical research field is likely to expand the IVD antibodies market size.
Furthermore, growing popularity of home healthcare and presence of user-friendly antibodies-based diagnostic products will further boost the demand for IVD antibodies in future.
There is no doubt that IVD antibodies have become highly-sought after diagnostic products used across healthcare facilities such as hospitals and diagnostic laboratories. However, there are some factors that are challenging the growth of IVD antibodies market. These factors include higher cost of the IVD antibodies, low product penetration, and lack of adequate healthcare facilities across lower economies.
Similarly, time consuming nature of research and development along with lengthy product approval process is negatively impacting market growth.
According to Future Market Insights, North America will continue to dominate the global antibodies market during the forecast period between 2022 and 2032. Growth in North America IVD antibodies market is driven by increasing drug research and development activities, higher product penetration, rising prevalence of cancer and cardiovascular diseases, availability of favorable reimbursement policies, and presence of leading IVD antibodies manufacturers.
Demand for IVD antibodies is especially rising across the USA due to surge in cancer cases, availability of highly advanced healthcare industry, increasing investments in research and development activities, and presence of leading pharmaceutical and biopharmaceutical giants.
The USA is home to one of the largest healthcare industries in the world. The country spends billions of dollars annually on medical research and drug development activities. For instance, annually the National Institutes of Health (NIH) alone spends around USD 41.7 billion in medical research for the American people. This is creating a conducive environment for the growth of IVD antibodies market in the region.
Similarly, growing popularity of point of care diagnostic will support the growth of IVD antibodies market during the forecast period.
Demand for IVD antibodies is anticipated to rise at a substantial pace across Europe during the forecast period, owing to the rising prevalence of various chronic and infectious diseases, surge in diagnostic procedures, increasing government support, and rapid expansion of healthcare industry.
Rising prevalence of cancer and other chronic diseases across countries like the UK and Germany due to factors such as excessive drinking and smoking, exposure to harmful radiations, and rapidly growing geriatric populations is fueling the demand for IVD antibodies.
According to Cancer Research UK, each year more than a third (36%) of all cancer cases in the UK are diagnosed in people aged 75 and over. Thus, rise in cancer cases due to increasing geriatric population will continue to play a key role in augmenting the growth of IVD antibodies market in the region.
Some of the leading manufacturers of IVD antibodies include Thermo Fisher Scientific, Rockland Immunochemicals Inc., Abcam plc., SDIX, LLC., GenScript, Bio-Rad Laboratories, Inc., HyTest Ltd., Biocare Medical, Advy Chemical Pvt. Ltd., MEDICAL & BIOLOGICAL LABORATORIES CO., LTD., and Abbott among others.
These leading players are rigorously investing in research and development to expand their product portfolios. Moreover, they have adopted various strategies such as new product launches and approvals, partnerships, collaborations, acquisitions, etc. to capitalize on the emerging opportunities and get a competitive edge in the market.
Companies like Biocare Medical, Thermo fisher Scientific, Bio-Rad Laboratories and Abcam plc. are likely to hold a significant share of the global IVD antibodies market through 2032. These players are continuously introducing new products to expand their portfolios and cater to the rising end user demands. For instance, in 2020 Biocare Medical launched seven novel IVD IHC antibody markers for clinical diagnostics and research applications.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 3.8% from 2022 to 2032 |
| Projected Market Size (2032) | 2 Billion |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, Application, End User, Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; APEJ; Japan; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | Thermo Fisher Scientific; Rockland Immunochemicals Inc.; Abcam plc.; SDIX, LLC.; GenScript; Bio-Rad Laboratories, Inc.; HyTest Ltd.; Advy Chemical Pvt. Ltd.; MEDICAL & BIOLOGICAL LABORATORIES CO., LTD.; Abbott |
| Customization | Available Upon Request |
Table 1: Global IVD Antibodies Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global IVD Antibodies Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 3: Global IVD Antibodies Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 4: Global IVD Antibodies Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 5: North America IVD Antibodies Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 6: North America IVD Antibodies Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 7: North America IVD Antibodies Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 8: North America IVD Antibodies Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 9: Latin America IVD Antibodies Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 10: Latin America IVD Antibodies Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 11: Latin America IVD Antibodies Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 12: Latin America IVD Antibodies Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 13: Europe IVD Antibodies Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Europe IVD Antibodies Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 15: Europe IVD Antibodies Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 16: Europe IVD Antibodies Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 17: East Asia IVD Antibodies Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 18: East Asia IVD Antibodies Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 19: East Asia IVD Antibodies Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 20: East Asia IVD Antibodies Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 21: South Asia & Pacific IVD Antibodies Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 22: South Asia & Pacific IVD Antibodies Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 23: South Asia & Pacific IVD Antibodies Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 24: South Asia & Pacific IVD Antibodies Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 25: MEA IVD Antibodies Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 26: MEA IVD Antibodies Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 27: MEA IVD Antibodies Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 28: MEA IVD Antibodies Market Value (US$ Mn) Forecast by End User, 2017-2032
Figure 1: Global IVD Antibodies Market Value (US$ Mn) by Product Type, 2022-2032
Figure 2: Global IVD Antibodies Market Value (US$ Mn) by Application, 2022-2032
Figure 3: Global IVD Antibodies Market Value (US$ Mn) by End User, 2022-2032
Figure 4: Global IVD Antibodies Market Value (US$ Mn) by Region, 2022-2032
Figure 5: Global IVD Antibodies Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 6: Global IVD Antibodies Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 7: Global IVD Antibodies Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 8: Global IVD Antibodies Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 9: Global IVD Antibodies Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 10: Global IVD Antibodies Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 11: Global IVD Antibodies Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 12: Global IVD Antibodies Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 13: Global IVD Antibodies Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 14: Global IVD Antibodies Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 15: Global IVD Antibodies Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 16: Global IVD Antibodies Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 17: Global IVD Antibodies Market Attractiveness by Product Type, 2022-2032
Figure 18: Global IVD Antibodies Market Attractiveness by Application, 2022-2032
Figure 19: Global IVD Antibodies Market Attractiveness by End User, 2022-2032
Figure 20: Global IVD Antibodies Market Attractiveness by Region, 2022-2032
Figure 21: North America IVD Antibodies Market Value (US$ Mn) by Product Type, 2022-2032
Figure 22: North America IVD Antibodies Market Value (US$ Mn) by Application, 2022-2032
Figure 23: North America IVD Antibodies Market Value (US$ Mn) by End User, 2022-2032
Figure 24: North America IVD Antibodies Market Value (US$ Mn) by Country, 2022-2032
Figure 25: North America IVD Antibodies Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 26: North America IVD Antibodies Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 27: North America IVD Antibodies Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 28: North America IVD Antibodies Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 29: North America IVD Antibodies Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 30: North America IVD Antibodies Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 31: North America IVD Antibodies Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 32: North America IVD Antibodies Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 33: North America IVD Antibodies Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 34: North America IVD Antibodies Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 35: North America IVD Antibodies Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 36: North America IVD Antibodies Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 37: North America IVD Antibodies Market Attractiveness by Product Type, 2022-2032
Figure 38: North America IVD Antibodies Market Attractiveness by Application, 2022-2032
Figure 39: North America IVD Antibodies Market Attractiveness by End User, 2022-2032
Figure 40: North America IVD Antibodies Market Attractiveness by Country, 2022-2032
Figure 41: Latin America IVD Antibodies Market Value (US$ Mn) by Product Type, 2022-2032
Figure 42: Latin America IVD Antibodies Market Value (US$ Mn) by Application, 2022-2032
Figure 43: Latin America IVD Antibodies Market Value (US$ Mn) by End User, 2022-2032
Figure 44: Latin America IVD Antibodies Market Value (US$ Mn) by Country, 2022-2032
Figure 45: Latin America IVD Antibodies Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 46: Latin America IVD Antibodies Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 47: Latin America IVD Antibodies Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 48: Latin America IVD Antibodies Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 49: Latin America IVD Antibodies Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 50: Latin America IVD Antibodies Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 51: Latin America IVD Antibodies Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 52: Latin America IVD Antibodies Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 53: Latin America IVD Antibodies Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 54: Latin America IVD Antibodies Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 55: Latin America IVD Antibodies Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 56: Latin America IVD Antibodies Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 57: Latin America IVD Antibodies Market Attractiveness by Product Type, 2022-2032
Figure 58: Latin America IVD Antibodies Market Attractiveness by Application, 2022-2032
Figure 59: Latin America IVD Antibodies Market Attractiveness by End User, 2022-2032
Figure 60: Latin America IVD Antibodies Market Attractiveness by Country, 2022-2032
Figure 61: Europe IVD Antibodies Market Value (US$ Mn) by Product Type, 2022-2032
Figure 62: Europe IVD Antibodies Market Value (US$ Mn) by Application, 2022-2032
Figure 63: Europe IVD Antibodies Market Value (US$ Mn) by End User, 2022-2032
Figure 64: Europe IVD Antibodies Market Value (US$ Mn) by Country, 2022-2032
Figure 65: Europe IVD Antibodies Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 66: Europe IVD Antibodies Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 67: Europe IVD Antibodies Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 68: Europe IVD Antibodies Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 69: Europe IVD Antibodies Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 70: Europe IVD Antibodies Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 71: Europe IVD Antibodies Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 72: Europe IVD Antibodies Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 73: Europe IVD Antibodies Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 74: Europe IVD Antibodies Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 75: Europe IVD Antibodies Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 76: Europe IVD Antibodies Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 77: Europe IVD Antibodies Market Attractiveness by Product Type, 2022-2032
Figure 78: Europe IVD Antibodies Market Attractiveness by Application, 2022-2032
Figure 79: Europe IVD Antibodies Market Attractiveness by End User, 2022-2032
Figure 80: Europe IVD Antibodies Market Attractiveness by Country, 2022-2032
Figure 81: East Asia IVD Antibodies Market Value (US$ Mn) by Product Type, 2022-2032
Figure 82: East Asia IVD Antibodies Market Value (US$ Mn) by Application, 2022-2032
Figure 83: East Asia IVD Antibodies Market Value (US$ Mn) by End User, 2022-2032
Figure 84: East Asia IVD Antibodies Market Value (US$ Mn) by Country, 2022-2032
Figure 85: East Asia IVD Antibodies Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 86: East Asia IVD Antibodies Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 87: East Asia IVD Antibodies Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 88: East Asia IVD Antibodies Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 89: East Asia IVD Antibodies Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 90: East Asia IVD Antibodies Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 91: East Asia IVD Antibodies Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 92: East Asia IVD Antibodies Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 93: East Asia IVD Antibodies Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 94: East Asia IVD Antibodies Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 95: East Asia IVD Antibodies Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 96: East Asia IVD Antibodies Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 97: East Asia IVD Antibodies Market Attractiveness by Product Type, 2022-2032
Figure 98: East Asia IVD Antibodies Market Attractiveness by Application, 2022-2032
Figure 99: East Asia IVD Antibodies Market Attractiveness by End User, 2022-2032
Figure 100: East Asia IVD Antibodies Market Attractiveness by Country, 2022-2032
Figure 101: South Asia & Pacific IVD Antibodies Market Value (US$ Mn) by Product Type, 2022-2032
Figure 102: South Asia & Pacific IVD Antibodies Market Value (US$ Mn) by Application, 2022-2032
Figure 103: South Asia & Pacific IVD Antibodies Market Value (US$ Mn) by End User, 2022-2032
Figure 104: South Asia & Pacific IVD Antibodies Market Value (US$ Mn) by Country, 2022-2032
Figure 105: South Asia & Pacific IVD Antibodies Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 106: South Asia & Pacific IVD Antibodies Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 107: South Asia & Pacific IVD Antibodies Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 108: South Asia & Pacific IVD Antibodies Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 109: South Asia & Pacific IVD Antibodies Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 110: South Asia & Pacific IVD Antibodies Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 111: South Asia & Pacific IVD Antibodies Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 112: South Asia & Pacific IVD Antibodies Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 113: South Asia & Pacific IVD Antibodies Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 114: South Asia & Pacific IVD Antibodies Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 115: South Asia & Pacific IVD Antibodies Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 116: South Asia & Pacific IVD Antibodies Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 117: South Asia & Pacific IVD Antibodies Market Attractiveness by Product Type, 2022-2032
Figure 118: South Asia & Pacific IVD Antibodies Market Attractiveness by Application, 2022-2032
Figure 119: South Asia & Pacific IVD Antibodies Market Attractiveness by End User, 2022-2032
Figure 120: South Asia & Pacific IVD Antibodies Market Attractiveness by Country, 2022-2032
Figure 121: MEA IVD Antibodies Market Value (US$ Mn) by Product Type, 2022-2032
Figure 122: MEA IVD Antibodies Market Value (US$ Mn) by Application, 2022-2032
Figure 123: MEA IVD Antibodies Market Value (US$ Mn) by End User, 2022-2032
Figure 124: MEA IVD Antibodies Market Value (US$ Mn) by Country, 2022-2032
Figure 125: MEA IVD Antibodies Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 126: MEA IVD Antibodies Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 127: MEA IVD Antibodies Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 128: MEA IVD Antibodies Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 129: MEA IVD Antibodies Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 130: MEA IVD Antibodies Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 131: MEA IVD Antibodies Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 132: MEA IVD Antibodies Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 133: MEA IVD Antibodies Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 134: MEA IVD Antibodies Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 135: MEA IVD Antibodies Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 136: MEA IVD Antibodies Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 137: MEA IVD Antibodies Market Attractiveness by Product Type, 2022-2032
Figure 138: MEA IVD Antibodies Market Attractiveness by Application, 2022-2032
Figure 139: MEA IVD Antibodies Market Attractiveness by End User, 2022-2032
Figure 140: MEA IVD Antibodies Market Attractiveness by Country, 2022-2032
As per FMI, demand in the global IVD antibodies market is expected to grow at around 7% CAGR during the forecast period.
North America is expected to continue its dominance in the global IVD antibodies market during the forecast period.
Thermo Fisher Scientific, Rockland Immunochemicals Inc., Abcam plc., SDIX, LLC., GenScript, Bio-Rad Laboratories, Inc., HyTest Ltd., Advy Chemical Pvt. Ltd., MEDICAL & BIOLOGICAL LABORATORIES CO., LTD., and Abbott are some of the leading players operating in IVD antibodies market.
IVD Antibodies Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
